organophosphonates has been researched along with Leukemia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bzowska, A; Glavas-Obrovac, L; Hashimoto, M; Hikishima, S; Magnowska, L; Suver, M; Yokomatsu, T | 1 |
| Araújo, RC; Barbosa, CM; Bincoletto, C; Caires, AC; Fausto, DM; Nascimento, FD; Oliveira, CR; Sena, E; Smith, MC; Soufen, MA; Tersariol, IL | 1 |
| Cermak, DM; Hohl, RJ; Lewis, KA; Wiemer, DF | 1 |
| Burt, HM; Duronio, V; Hunter, W; Jackson, JK; Lauener, RW; Mouhajir, F; Oktaba, AM; Salari, H; Scheid, MP; Shen, Y | 1 |
| Benvenuto, JA; Beran, M; Estey, E; Felder, TB; Keating, M; O'Brien, S | 1 |
1 trial(s) available for organophosphonates and Leukemia
| Article | Year |
|---|---|
Phase I clinical investigation of benzisoquinolinedione (amonafide) in adults with refractory or relapsed acute leukemia.
Topics: Acute Disease; Adenine; Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Female; Humans; Imides; Isoquinolines; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Naphthalimides; Organophosphonates; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1991 |
4 other study(ies) available for organophosphonates and Leukemia
| Article | Year |
|---|---|
Antiproliferative activity of purine nucleoside phosphorylase multisubstrate analogue inhibitors containing difluoromethylene phosphonic acid against leukaemia and lymphoma cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Enzyme Inhibitors; Guanine; Humans; Kinetics; Leukemia; Lymphoma; Organophosphonates; Purine-Nucleoside Phosphorylase; Substrate Specificity | 2010 |
Biphosphinic palladacycle complex mediates lysosomal-membrane permeabilization and cell death in K562 leukaemia cells.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 6; Cell Survival; Diphosphonates; Dose-Response Relationship, Drug; Enzyme Activation; Gene Expression; Humans; Hydrogen-Ion Concentration; Intracellular Membranes; K562 Cells; Kidney; Leukemia; Liver; Lysosomes; Mice; Microscopy, Confocal; Organometallic Compounds; Organophosphonates; Palladium; Permeability; Proto-Oncogene Proteins c-bcl-2; Spectrophotometry, Infrared | 2006 |
Stereochemistry-dependent inhibition of RAS farnesylation by farnesyl phosphonic acids.
Topics: Alkyl and Aryl Transferases; Cholesterol; Enzyme Inhibitors; Farnesol; Farnesyl-Diphosphate Farnesyltransferase; Humans; Leukemia; Molecular Conformation; Organophosphonates; Protein Prenylation; ras Proteins; Structure-Activity Relationship; Substrate Specificity; Tumor Cells, Cultured | 1998 |
The antineoplastic ether lipid, s-phosphonate, selectively induces apoptosis in human leukemic cells and exhibits antiangiogenic and apoptotic activity on the chorioallantoic membrane of the chick embryo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Chick Embryo; Chorion; HL-60 Cells; Humans; In Vitro Techniques; Leukemia; Neovascularization, Pathologic; Organophosphonates; Phospholipids; Tumor Cells, Cultured | 1998 |